Dasbach E J, Davies G M, Teutsch S M
Merck Research Laboratories, Blue Bell, PA 19422, USA.
Clin Infect Dis. 2000 Dec;31(6):1524-8. doi: 10.1086/317487.
In the United States in 1996, there were an estimated 10,190 aspergillosis-related hospitalizations (95% confidence interval [CI], 9000-11,380); these resulted in 1970 deaths (95% CI, 1659-2280), 176,272 hospital days (95% CI, 147,163-206,275), and $633.1 million in costs (95% CI, $492.0-$780.2 million). The average hospitalization lasted 17.3 days (95% CI, 16.1-18.6) and cost $62,426 (95% CI, $52,670-$72,181). Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates.
1996年在美国,估计有10190例与曲霉病相关的住院病例(95%置信区间[CI],9000 - 11380);这些病例导致1970人死亡(95% CI,1659 - 2280),住院天数达176272天(95% CI,147163 - 206275),费用为6.331亿美元(95% CI,4.920亿 - 7.802亿美元)。平均住院时间为17.3天(95% CI,16.1 - 18.6),费用为62426美元(95% CI,52670 - 72181美元)。尽管与曲霉病相关的住院病例在美国住院病例中占比很小,但因该病住院的患者住院时间长且死亡率高。